Mangla Ashvarya, Gupta Saurabh
Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, United States.
Director, Cardiac Catheterization Laboratories, Associate Professor of Medicine (Clinical), Oregon Health & Science University, Portland, OR 97239, United States.
Indian Heart J. 2016 Sep-Oct;68(5):724-731. doi: 10.1016/j.ihj.2015.11.024. Epub 2016 Jan 12.
Transcatheter aortic valve replacement (TAVR) has rapidly emerged as the standard of care for severe symptomatic aortic stenosis in patients whose comorbidities put them at prohibitive risk for surgical aortic valve replacement (SAVR). Several trials have demonstrated superior outcomes with TAVR compared to medical management alone. TAVR has also shown favorable outcomes in patients at high risk for SAVR. TAVR can be associated with significant vascular complications, which adversely impact outcomes, and operators should be cognizant of their early recognition and appropriate management. In this article, we review the major vascular complications associated with TAVR, along with optimal prevention and management strategies.
经导管主动脉瓣置换术(TAVR)已迅速成为患有合并症而使其接受外科主动脉瓣置换术(SAVR)风险过高的严重症状性主动脉瓣狭窄患者的治疗标准。多项试验表明,与单纯药物治疗相比,TAVR的疗效更佳。TAVR在SAVR高风险患者中也显示出良好的疗效。TAVR可能会伴有严重的血管并发症,这会对治疗结果产生不利影响,操作人员应认识到对其进行早期识别和适当处理的重要性。在本文中,我们回顾了与TAVR相关的主要血管并发症,以及最佳的预防和处理策略。